The need for well-controlled biospecimen management is often severely underestimated.  As studies scale from single to multiple sites, there can be a dramatic drop in the collection and processing of precious study samples in a consistent and reproducible manner.   With this in mind, Precision Oncology created state-of-the-art infrastructure and processes to track, receive and process samples consistently across sites. We do this globally and with a relentless focus on quality, logistics and standardization.  Highlights of our infrastructure include...

A comprehensive biomarker strategy covers a range of specialty assays that are fit-for-purpose, and can be custom-designed and fully validated, if needed.   We can deliver these assays as individual pieces or as a package of assays that are analyzed together via our propriety analytics platform, delivering unprecedented insights to sponsors...

Precision Oncology has responded to the demands of biomarker-guided drug development by engineering the PATH™ Analytics Platform, a cloud-based predictive analytics engine and knowledge-generation platform specifically engineered to address the complexities of high-throughput, high-content biological data in the context of translational research...

For any biomarkers that demonstrate promise as a companion or complementary diagnostic, Precision Oncology provides services to enable the complete development and global registration of these diagnostics.  To date, our team has completed...